Otsuka Pharmaceutical

www.otsuka.co.jp

2-9 Kanda Tsukasa-machi
Chiyodu-ku
Tokyo
101-8535
Japan

+81352972727

Activities

Distribution | Manufacturing | Research & Development | Nutraceutical

Related Companies

Related Content

ERS Genomics licenses CRISPR gene editing tech to Otsuka
ERS Genomics licenses CRISPR gene editing tech to Otsuka
Therapeutics: difamilast for atopic dermatitis
Therapeutics: difamilast for atopic dermatitis
The FDA approves pill able to detect if patients have ingested medication
The FDA approves pill able to detect if patients have ingested medication
To go or not to go: the question the UK must answer
To go or not to go: the question the UK must answer
Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
Otsuka Pharmaceutical to purchase Avanir Pharmaceuticals for US$3.5bn
Otsuka Pharmaceutical to purchase Avanir Pharmaceuticals for US$3.5bn
NCEs target cancer
NCEs target cancer
Otsuka Pharmaceutical to purchase Astex
Otsuka Pharmaceutical to purchase Astex
Almac receives appreciation award from Otsuka America Pharmaceutical
Almac receives appreciation award from Otsuka America Pharmaceutical
Otsuka establishes new European division in the UK
Otsuka establishes new European division in the UK
Joint venture opens door to Japanese market
Joint venture opens door to Japanese market
Catalent to supply Abilify OD tablets to Otsuka
Catalent to supply Abilify OD tablets to Otsuka
Lundbeck and Otsuka to deliver psychiatric products
Lundbeck and Otsuka to deliver psychiatric products